Head of unit: Per Eriksson
Research focus: Cardiovascular disease
The long-term interest of the Eriksson team is to study the molecular mechanisms underlying aortic aneurys.
Our research is focused on immune mechanisms in atherosclerosis development.
Lars Maegdefessel’s group performs translational studies in atherosclerosis research, focussing on the therapeutic and biomarker potential of non-codingRNAs (e.g., microRNAs and lncRNAs) and other epigenetic modulators in vascular disease and its underlying (patho-) mechanisms.